Paulas Choice Clear Anti Redness Exfoliating Solution

Manufacturer
Paula's Choice, LLC.
Effective date
2022-06-06
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:18:50

Label at a glance#

ProductPaulas Choice Clear Anti Redness Exfoliating Solution
Active ingredientSALICYLIC ACID
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid

OTC - PURPOSE SECTION

  • Treats acne
  • Helps clear acne blemishes, blackheads, and whiteheads
  • Helps prevent new acne blemishes

DOSAGE & ADMINISTRATION SECTION

After cleansing with Paula's Choice Clear Pore Normalizing Cleanser, soak a large cotton ball with Regular Strength Anti-Redness Exfoliating Solution and gently stroke over the face, paying special attention to acne and blackhead prone areas. Do not rinse. Avoid contact with eyes, eyelids, and mucous membranes. If contact occurs, rinse with water. If excessive dryness or peeling occurs, reduce application to once per day or once every other day.

INDICATIONS & USAGE SECTION

If contact occurs, rinse with water. If excessive dryness or peeling occurs, reduce application to once per day or once every other day.

WARNINGS SECTION

Warnings

For external use only.

OTC - DO NOT USE SECTION

Do not use

  • on broken skin
  • on large areas of the body

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if too much skin irritation or skin sensitivity develops or increases.

OTC - WHEN USING SECTION

When using this product

· Do not use in or near the eyes

· Using other topical acne products at the same time or right after use of this product may increase dryness or irritation of the skin. If this occurs, only one drug should be used unless directed by a doctor.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help and contact a Poison Control Center immediately.

OTHER SAFETY INFORMATION

  • Store at 20-25ºC (68-77ºF).
  • You may report serious adverse reactions to 1030 SW 34th Street, Suite A, Renton, WA 98057

INACTIVE INGREDIENT SECTION

Water, Dipropylene Glycol, Pentylene Glycol, Polysorbate 20, Butylene Glycol, Glycerin, Sodium Hyaluronate, Dipotassium Glycyrrhizate, Allantoin. Panthenol, PEG/PPG-17/6 Copolymer, Methyl Gluceth-20, Glycereth-26, Bis-PEG-18 Methyl Ether Dimethyl Silane, Sodium Hydroxide, Sodium Metabisulfite, Tetrasodium EDTA

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Full Size Component LabelFull Size Component Label

Trial Size Artwork

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Trial Size ArtworkTrial Size Artwork

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76144-62076144-620-01, 76144-620-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c54e1794-a620-5163-e053-2995a90a472519ac69ad-d2b7-3aaa-e054-00144ff88e882022-06-06WarningsExact identifier
spl id: c54e1794-a620-5163-e053-2995a90a4725
spl set id: 19ac69ad-d2b7-3aaa-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.